Four independent studies show rovalpituzumab tesirine ineffective against small cell lung cancer — ScienceDaily
Four independent studies published in the Journal of Thoracic Oncology (JTO) demonstrate that rovalpituzumab tesirine for small-cell lung cancer (SCLC) is not effective against SCLC, casting a pall over the…

